TherapeuticsMD
TXMD
#10601
Rank
NZ$40.23 M
Marketcap
NZ$3.48
Share price
0.49%
Change (1 day)
86.97%
Change (1 year)

Earnings for TherapeuticsMD (TXMD)

Earnings in 2026 (TTM): NZ$0.15 Million

According to TherapeuticsMD's latest financial reports the company's current earnings are NZ$3.35 Million. In 2025 the company made an earning of -NZ$1.12 Million, an increase over its 2024 earnings that were of -NZ$4 Million. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for TherapeuticsMD from 1999 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$0.15 M-114.23%
2025 -NZ$1.12 Million-72.13%
2024 -NZ$4 Million-69.74%
2023 -NZ$13.2 Million-90.43%
2022 -NZ$0.14 Billion-53.08%
2021 -NZ$0.3 Billion-6.05%
2020 -NZ$0.32 Billion4.19%
2019 -NZ$0.31 Billion32.82%
2018 -NZ$0.23 Billion72.4%
2017 -NZ$0.14 Billion-14.41%
2016 -NZ$0.16 Billion5.64%
2015 -NZ$0.15 Billion56.92%
2014 -NZ$92.39 Million90.65%
2013 -NZ$48.46 Million-19.03%
2012 -NZ$59.85 Million118.63%
2011 -NZ$27.38 Million2151.02%
2010 -NZ$1.22 Million-30.41%
2009 -NZ$1.75 Million159.24%
2008 -NZ$0.68 Million10.53%
2007 -NZ$0.61 Million-174.09%
2006 NZ$0.82 M29.72%
2005 NZ$0.63 M146.61%
2004 NZ$0.25 M45.03%
2003 NZ$0.17 M5.25%
2002 NZ$0.16 M60.74%
2001 NZ$0.1 M-53.26%
2000 NZ$0.22 M959.35%
1999 NZ$0.02 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
NZ$18.04 B 8,975,323.73%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$10.18 B 5,063,459.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Agile Therapeutics
AGRX
-NZ$25.61 Million-12,833.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Royalty Pharma
RPRX
NZ$2.88 B 1,436,459.32%๐Ÿ‡ฌ๐Ÿ‡ง UK
Lannett Company
LCI
-NZ$0.34 Billion-168,158.47%๐Ÿ‡บ๐Ÿ‡ธ USA